Spots Global Cancer Trial Database for nivolumab injection [opdivo]
Every month we try and update this database with for nivolumab injection [opdivo] cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Nivolumab Combined With Chemotherapy in the Treatment of Primary Tracheal Squamous Cell Carcinoma | NCT05964101 | Neoplasms Carcinoma, Squa... Antineoplastic ... | Nivolumab Injec... | 18 Years - 75 Years | The First Affiliated Hospital of Guangzhou Medical University | |
CVM-1118 in Combination With Nivolumab for Unresectable Advanced Hepatocellular Carcinoma | NCT05257590 | Hepatocellular ... Advanced Cancer | Nivolumab Injec... CVM-1118 | 18 Years - | TaiRx, Inc. | |
Melanoma Metastasized to the Brain and Steroids | NCT03563729 | Malignant Melan... | Pembrolizumab I... Ipilimumab Inje... Nivolumab Injec... Encorafenib Binimetinib Dabrafenib Trametinib | 18 Years - | Herlev Hospital | |
Combined Immunotherapy and Radiosurgery for Metastatic Colorectal Cancer | NCT03507699 | Colorectal Neop... Liver Metastase... | Liver radiation... Nivolumab Injec... Ipilimumab Inje... CMP-001 | 18 Years - | Sheba Medical Center | |
Nivolumab Combined With Chemotherapy in the Treatment of Primary Tracheal Squamous Cell Carcinoma | NCT05964101 | Neoplasms Carcinoma, Squa... Antineoplastic ... | Nivolumab Injec... | 18 Years - 75 Years | The First Affiliated Hospital of Guangzhou Medical University | |
Melanoma Metastasized to the Brain and Steroids | NCT03563729 | Malignant Melan... | Pembrolizumab I... Ipilimumab Inje... Nivolumab Injec... Encorafenib Binimetinib Dabrafenib Trametinib | 18 Years - | Herlev Hospital | |
A Trial to Evaluate Safety and Tolerability of TST001 in Advanced or Metastatic Solid Tumors | NCT04396821 | Advanced Cancer Gastric Cancer Gastroesophagea... Pancreatic Canc... | TST001 Nivolumab Injec... mFOLFOX6 Gemcitabine Albumin-Bound P... | 18 Years - | Suzhou Transcenta Therapeutics Co., Ltd. | |
Nivolumab Combined With Chemotherapy in the Treatment of Primary Tracheal Squamous Cell Carcinoma | NCT05964101 | Neoplasms Carcinoma, Squa... Antineoplastic ... | Nivolumab Injec... | 18 Years - 75 Years | The First Affiliated Hospital of Guangzhou Medical University | |
Neoadjuvant and Adjuvant Nivolumab in HCC Patients Treated by Electroporation | NCT03630640 | Hepatocellular ... | Nivolumab Injec... | 18 Years - 99 Years | Assistance Publique - Hôpitaux de Paris | |
Melanoma Metastasized to the Brain and Steroids | NCT03563729 | Malignant Melan... | Pembrolizumab I... Ipilimumab Inje... Nivolumab Injec... Encorafenib Binimetinib Dabrafenib Trametinib | 18 Years - | Herlev Hospital | |
Neoadjuvant and Adjuvant Nivolumab in HCC Patients Treated by Electroporation | NCT03630640 | Hepatocellular ... | Nivolumab Injec... | 18 Years - 99 Years | Assistance Publique - Hôpitaux de Paris | |
Neoadjuvant and Adjuvant Nivolumab in HCC Patients Treated by Electroporation | NCT03630640 | Hepatocellular ... | Nivolumab Injec... | 18 Years - 99 Years | Assistance Publique - Hôpitaux de Paris | |
Checkpoint Inhibitors and SBRT for mCRPC | NCT05655715 | Prostate Cancer... Castrate Resist... Metastatic Cast... Prostate Cancer... | Stereotactic bo... Ipilimumab Inje... Nivolumab Injec... Biopsies | 18 Years - | Herlev and Gentofte Hospital | |
Phase I Study VG2025 as a Single Agent and in Combination Therapy With Nivolumab in Subjects With Advanced Malignant Solid Tumors | NCT05266612 | Solid Tumor | VG2025 Nivolumab Injec... | 18 Years - | Virogin Biotech Ltd. |